Feline Toxoplasmosis: Zoonotic Risk, Clinical Manifestations, and Prevention in Pregnant Women and Immunocompromised Individuals

Etiology and Life Cycle of Toxoplasma gondii

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a heteroxenous life cycle. Felids, including domestic cats, serve as the definitive host in which sexual reproduction occurs within the intestinal epithelium [1]. The parasite exists in three infectious stages: tachyzoites (rapidly dividing forms), bradyzoites (slowly dividing forms contained within tissue cysts), and sporozoites (contained within sporulated oocysts) [1, 2]. The sexual cycle culminates in the production of unsporulated oocysts that are shed in feline feces. Oocysts sporulate and become infectious within 1 to 5 days under appropriate environmental conditions of temperature and humidity [3, 4].

The enteroepithelial cycle in cats begins following ingestion of tissue cysts from intermediate hosts (e.g., rodents, birds) or sporulated oocysts from the environment [1, 2]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract has elucidated the transcriptional dynamics of gametocyte formation and oocyst wall biosynthesis [1]. Following primary infection, cats may shed millions of oocysts over a period of 1 to 3 weeks [3, 4]. Oocyst shedding typically occurs only once in a cat's lifetime, although reinfection can occasionally induce limited shedding [4, 5].

Intermediate hosts, including humans, become infected through ingestion of sporulated oocysts from contaminated soil, water, or food, or through ingestion of tissue cysts in undercooked meat [6, 7, 8]. Transplacental transmission occurs when a pregnant female acquires a primary infection during gestation [9, 10]. The parasite's ability to manipulate host behavior, including altered risk perception and activity levels in infected rodents, has been documented and may enhance transmission to felids [11].

Epidemiology and Zoonotic Risk

Toxoplasma gondii infection is distributed globally, with seroprevalence varying widely by geographic region, host species, and management practices [12, 8, 4]. Seroprevalence in cats ranges from low single digits to over 70 percent depending on the population studied [12, 4]. In Hong Kong, seroprevalence in privately owned cats was reported at 8.4 percent, while community cats showed higher rates [12]. In Jordan, seroprevalence in cats was 41.3 percent with risk factors including age, outdoor access, and raw meat consumption [4].

The zoonotic risk posed by feline toxoplasmosis is primarily mediated by environmental contamination with oocysts [13, 3]. Social marginalisation and environmental degradation in urban informal settlements have been associated with increased T. gondii exposure, likely due to poor sanitation and high densities of free-roaming cats [13]. Oocyst survival in soil and water is prolonged in temperate and humid climates, contributing to sustained transmission pressure [13, 8].

The specific concern regarding cat toxoplasmosis baby transmission arises from the risk of congenital infection. Primary maternal infection acquired during pregnancy can result in transplacental transmission to the fetus, leading to potentially severe outcomes including chorioretinitis, intracranial calcifications, hydrocephalus, and fetal death [9, 14]. The risk of fetal infection increases with gestational age, while the severity of disease decreases [9, 14]. Seroprevalence studies in women with a history of abortion or stillbirth have demonstrated significantly higher anti-T. gondii antibody seropositivity compared to controls, supporting the association between infection and adverse pregnancy outcomes [9].

Immunocompromised individuals, including organ transplant recipients, patients receiving immunosuppressive therapy, and those with HIV/AIDS, are at elevated risk for reactivation of latent toxoplasmosis [15, 16]. Cerebral toxoplasmosis is a particularly severe manifestation in this population, presenting with focal neurological deficits, seizures, and mass lesions on neuroimaging [16]. Patients with sickle cell disease receiving blood transfusions also show increased seropositivity, potentially due to transfusion-associated transmission [15].

Clinical Manifestations in Cats

Most immunocompetent cats infected with T. gondii remain asymptomatic [4, 5]. When clinical signs do occur, they are most commonly observed in kittens or immunocompromised cats. The primary clinical syndromes include:

Fever, lethargy, and anorexia are common nonspecific findings [5, 17]. Respiratory signs such as dyspnea and tachypnea may result from pulmonary involvement [5]. Ocular manifestations include uveitis, chorioretinitis, and anterior chamber inflammation [18, 19]. Neurological signs, including ataxia, seizures, tremors, and behavioral changes, reflect central nervous system involvement [16, 11]. Hepatic and pancreatic involvement can produce icterus and vomiting [5, 17].

A retrospective study of 72 cats presenting with pyogranulomatous and neutrophilic lymphadenitis identified T. gondii as a differential diagnosis in cases of systemic inflammatory disease [17]. The pathogenesis of clinical toxoplasmosis involves tissue necrosis and inflammation secondary to tachyzoite replication within host cells [5, 17].

Pathology and Pathogenesis

The pathological hallmark of acute toxoplasmosis is multifocal necrosis with a mixed inflammatory infiltrate composed of neutrophils, macrophages, and lymphocytes [10, 17]. In the feline small intestine, infection induces dynamic changes in microRNA expression, with upregulation of miR-146a and miR-155 associated with modulation of the host inflammatory response [2]. Tissue cysts containing bradyzoites are most commonly found in the brain, skeletal muscle, and myocardium [10, 8].

In aborted fetuses, T. gondii can be detected in myocardial tissue using histopathological examination and molecular methods [10]. The parasite induces pyogranulomatous inflammation with necrosis and mineralization in affected tissues [10, 20]. Reproductive tissues from companion animals enrolled in neutering programs have demonstrated T. gondii DNA, indicating potential for vertical transmission [20].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods.

Serological testing detects anti-T. gondii antibodies, primarily IgM and IgG. Commercial ELISA kits are widely used for screening [21, 22]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed and validated for detection of T. gondii antibodies across multiple host species, including cats [21]. This point-of-care assay uses recombinant SAG1 antigen and provides results within 15 minutes [21, 22]. Seroprevalence surveys in cats and other animals routinely employ ELISA or indirect immunofluorescence assays [12, 23, 4].

Molecular detection using polymerase chain reaction (PCR) targets repetitive DNA sequences such as the B1 gene or the 529 bp repeat element [3, 5]. An antisense PCR assay has been developed specifically for T. gondii detection in domestic cats, demonstrating improved sensitivity compared to conventional PCR [5]. Fecal PCR is used to detect oocyst shedding in cats, although shedding is intermittent and of short duration [3, 4].

Histopathological examination of tissues reveals characteristic cysts and tachyzoites, often with associated inflammation [10, 17]. Immunohistochemistry using antibodies against T. gondii antigens can confirm the diagnosis in tissue sections [10].

The following table summarizes the diagnostic modalities for feline toxoplasmosis:

Treatment and Clinical Management

Treatment of clinical toxoplasmosis in cats involves antiprotozoal therapy. Clindamycin is the first-line agent, administered at 10 to 12 mg/kg orally every 12 hours for 2 to 4 weeks [5, 17]. Alternative regimens include trimethoprim-sulfonamide combinations or pyrimethamine combined with a sulfonamide [5]. Adjunctive therapy with corticosteroids may be indicated for ocular or central nervous system inflammation [18, 17].

Supportive care includes fluid therapy, nutritional support, and management of secondary infections [5, 17]. Cats with neurological signs may require anticonvulsant therapy and intensive monitoring [16, 11].

Prevention Strategies for Pregnant Women and Immunocompromised Individuals

Prevention of zoonotic transmission from cats to humans, particularly in the context of cat toxoplasmosis baby risk, requires a multifaceted approach. The following strategies are recommended:

Litter box management. Pregnant women and immunocompromised individuals should avoid cleaning litter boxes if possible [14]. If no alternative exists, gloves should be worn and hands washed thoroughly afterward. Litter boxes should be cleaned daily, as oocysts require 1 to 5 days to sporulate and become infectious [3, 4]. Disposal of feces in sealed bags is recommended.

Environmental hygiene. Cats should be kept indoors to prevent hunting of intermediate hosts and exposure to contaminated soil [4, 14]. Sandboxes and garden areas should be covered to prevent defecation by free-roaming cats [13, 14]. Hand washing after gardening or contact with soil is essential.

Dietary precautions. Cats should be fed commercial cooked or canned food rather than raw meat [4, 5]. Humans should avoid consumption of undercooked meat, particularly lamb, pork, and game [6, 24]. Washing fruits and vegetables thoroughly reduces the risk of oocyst ingestion [13, 14].

Serological screening. Pregnant women who are seronegative for T. gondii should be counseled regarding preventive measures [9, 25, 14]. Knowledge and practices regarding toxoplasmosis among pregnant women vary widely, and educational interventions are needed to improve compliance with preventive recommendations [25, 26]. Veterinary medicine professionals and students have higher seroprevalence than the general population, underscoring the importance of occupational hygiene [27].

Immunocompromised individuals. Patients receiving immunosuppressive therapy or with HIV/AIDS should be advised to adopt strict hygiene measures [15, 16]. Prophylactic antimicrobial therapy may be indicated in certain high-risk populations [16]. Regular serological monitoring can identify seroconversion early [15, 16].

The following Mermaid diagram illustrates the decision framework for managing cat toxoplasmosis baby risk in a household with a pregnant woman:

flowchart TD
    A[Pregnant woman or immunocompromised individual in household with cat], > B{Is the cat seropositive?}
    B, >|Yes| C[Cat is likely immune; low risk of shedding]
    B, >|No| D[Cat is susceptible; risk of primary infection]
    D, > E{Is the cat strictly indoor?}
    E, >|Yes| F[Low risk of acquiring infection]
    E, >|No| G[High risk; restrict outdoor access]
    G, > H[Implement litter box hygiene]
    H, > I[Daily cleaning by non-at-risk person]
    I, > J[Feed only commercial cooked food]
    J, > K[Monitor cat for clinical signs]
    K, > L[If signs develop, test and treat]
    C, > M[Continue routine preventive measures]
    F, > M
    L, > M
    M, > N[Educate household on hygiene]
    N, > O[Reduce zoonotic transmission risk]

Control in Animal Populations

Control of T. gondii in animal populations reduces environmental contamination and zoonotic risk. In cats, preventing access to intermediate hosts and feeding only cooked or commercial diets are effective measures [4, 5]. Neutering programs reduce the population of free-roaming cats, thereby decreasing oocyst contamination of the environment [20].

Vaccine development for T. gondii is an active area of research. Gene-edited live-attenuated vaccines have shown promise in preclinical studies, with deletion of genes essential for virulence or persistence [28]. Advances in antigen discovery and mRNA vaccine platforms are being explored for both veterinary and human applications [29]. However, no licensed vaccine for feline toxoplasmosis is currently available.

In livestock, biosecurity measures including rodent control, proper feed storage, and preventing cat access to animal housing reduce infection rates [6, 30, 24]. Seroprevalence in pigs, goats, and cattle varies widely and is influenced by management practices [6, 30, 24]. Sheep and goats are particularly susceptible to reproductive losses from T. gondii infection [6, 10].

Public Health Implications

The public health significance of feline toxoplasmosis is substantial. Oocyst contamination of soil and water in urban and rural environments poses a risk to humans and wildlife [13, 8]. Migratory and opportunistic wild and domestic birds serve as carriers, contributing to geographic dissemination [7]. Wildlife in China, including rodents, birds, and ungulates, show high seroprevalence, indicating widespread environmental contamination [8].

Ocular toxoplasmosis is a leading cause of posterior uveitis in many regions [18, 19]. Risk factors for ocular disease include infection with certain parasite genotypes and host immune status [18, 19]. In quilombola communities in Brazil, ocular health assessments have identified associations between T. gondii seropositivity and retinal lesions [19].

Childhood T. gondii infection has been associated with psychotic experiences and reduced grey matter volume in population-based cohort studies, suggesting potential neurodevelopmental effects [31]. These findings highlight the importance of preventing primary infection in all age groups, not only pregnant women.

References

[1] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/

[2] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[3] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[4] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[5] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[6] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[7] Tsakmakidis I, Moustakidis K, Alvanou MV et al. Migratory and opportunistic wild and domestic birds, as Toxoplasma gondii carriers. Parasite Epidemiol Control. 2026. https://pubmed.ncbi.nlm.nih.gov/41970607/

[8] Zhu XK, Cong W, Meng QF. Toxoplasma gondii infection in wildlife in China (1985-2024): A systematic review and meta-analysis with machine learning. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41747478/

[9] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[10] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[11] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. https://pubmed.ncbi.nlm.nih.gov/41481062/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[12] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[13] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[14] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/

[15] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/

[16] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/

[17] Doyle E, Walker J. Diagnosis of pyogranulomatous and neutrophilic lymphadenitis in 72 cats presenting to a referral hospital: with a focus on nine cats with steroid-responsive lymphadenitis. J Feline Med Surg. 2026. https://pubmed.ncbi.nlm.nih.gov/41527158/

[18] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/

[19] Filho SCC, Moron SE, Ferreira RG et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/

[20] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/

[21] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[22] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[23] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[24] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/

[25] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/

[26] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/

[27] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[28] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[29] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[30] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[31] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/

[32] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[33] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[34] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[35] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/